Boreo's organic sales continued growing in Q2 for the third quarter in a row, showing double-digit growth in both business areas. On the other hand, oper. EBIT was somewhat down y/y, but close to our expectation. The company commented that the outlook for H2 seems reasonable, while market uncertainties remain elevated. We do not see big changes in the investment story.

SEB Research

This research has been commissioned by the company. Only for professional investors resident in EEA member states. Reports may not be distributed to the US or other jurisdictions where to do so would be unlawful. Please see the disclaimer tab for any details of investment banking services recently provided by SEB that could be considered relevant to the subject matter of this research.

Läs mer på SEB Research

Ämnen i artikeln

Boreo

Senast

20,60

1 dag %

−1,90%

1 dag

1 mån

1 år

Marknadsöversikt

1 DAG %

Senast

1 mån